Cas No.: | 1910124-24-1 |
Chemical Name: | (R)-N-(1 ,3- dimethyl-6-(2-methylpiperazin-1 -yl)-2-oxo-2,3-dihydro-1 H-benzo[d]imidazol-5-yl)-2- methoxybenzamide |
Synonyms: | GSK6853;GSK-6853;GSK 6853 |
SMILES: | C1C=C(C(NC2C=C3C(N(C(N3C)=O)C)=CC=2N2[C@H](C)CNCC2)=O)C(OC)=CC=1 |
Formula: | C22H27N5O3 |
M.Wt: | 409.21 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | GSK6853 is a potent and selective inhibitor of the BRPF1 bromodomain. shows excellent BRPF1 potency (pKd 9.5) andgreater than 1600-fold selectivity over all other bromodomainstested.target: BRPF1.[1]In vivo: The ip route of administration would be suitable for dosing GSK6853 in potential PK/PD models. [1] |